Report overview
This report aims to provide a comprehensive presentation of the global market for Therapeutic Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Therapeutic Vaccines. This report contains market size and forecasts of Therapeutic Vaccines in global, including the following market information:
Global Therapeutic Vaccines Market Revenue, 2019-2024, 2024-2029, ($ millions)
Global Therapeutic Vaccines Market Sales, 2019-2024, 2024-2029, (K Units)
Global top five Therapeutic Vaccines companies in 2023 (%)
The global Therapeutic Vaccines market was valued at US$ 31940 million in 2023 and is projected to reach US$ 112360 million by 2029, at a CAGR of 19.7% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Peptide Therapeutic Vaccine Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Therapeutic Vaccines include Northeast Biotherapeutics, Agenus, Vaccinogen Inc, CIMAB S.A, Dendreon, Corixa and AVAX Technologies, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Therapeutic Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Therapeutic Vaccines Market, by Type, 2019-2024, 2024-2029 ($ Millions) & (K Units)
Global Therapeutic Vaccines Market Segment Percentages, by Type, 2023 (%)
Peptide Therapeutic Vaccine
Cell Therapeutic Vaccine
Nucleic Acid Therapeutic Vaccine
Global Therapeutic Vaccines Market, by Application, 2019-2024, 2024-2029 ($ Millions) & (K Units)
Global Therapeutic Vaccines Market Segment Percentages, by Application, 2023 (%)
Oncotherapy
Hepatitis B
Tuberculosis
Herpes Simplex Virus
Others
Global Therapeutic Vaccines Market, By Region and Country, 2019-2024, 2024-2029 ($ Millions) & (K Units)
Global Therapeutic Vaccines Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Therapeutic Vaccines revenues in global market, 2019-2024 (Estimated), ($ millions)
Key companies Therapeutic Vaccines revenues share in global market, 2023 (%)
Key companies Therapeutic Vaccines sales in global market, 2019-2024 (Estimated), (K Units)
Key companies Therapeutic Vaccines sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Northeast Biotherapeutics
Agenus
Vaccinogen Inc
CIMAB S.A
Dendreon
Corixa
AVAX Technologies
Outline of Major Chapters:
Chapter 1: Introduces the definition of Therapeutic Vaccines, market overview.
Chapter 2: Global Therapeutic Vaccines market size in revenue and volume.
Chapter 3: Detailed analysis of Therapeutic Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Therapeutic Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Therapeutic Vaccines capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
